Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS) [PDF]
core +1 more source
Management of osteoporosis in central and eastern Europe (CEE): conclusions of the “2nd Summit on Osteoporosis—CEE”, 21–22 November 2008, Warsaw, Poland [PDF]
Roman S. Lorenc +38 more
core +1 more source
Decortication in the Surgical Management of Complete Atypical Femoral Fractures: A Strategy to Accelerate Fracture Healing. [PDF]
Cho YH, Lim C, Kim D.
europepmc +1 more source
Comparing the efficacy of teriparatide and bisphosphonates in osteoporotic patients undergoing thoracolumbar spinal fusion: a meta-analysis. [PDF]
Ji X, Duan J, He G, Wang J, Xing Z.
europepmc +1 more source
Preliminary analysis of combined romosozumab and denosumab versus teriparatide and denosumab on bone mineral density. [PDF]
Chiang MH +9 more
europepmc +1 more source
Radiographic Evolution of Contralateral Asymptomatic Incomplete Atypical Femoral Fractures in Autoimmune Disease Patients. [PDF]
Nishino T +7 more
europepmc +1 more source
Senile thoracolumbar tuberculosis with kyphosis and severe osteoporosis treated with polymethylmethacrylate-augmented screw fixation. [PDF]
Kumar BY, Loganathan B, Vijayakumar D.
europepmc +1 more source
Can P1NP Levels Influence Management Planning for Patients With a Fragility Hip Fracture Receiving Anti-resorptive Medications? [PDF]
Kraidi M, Wilkinson I, Bandyopadhyay S.
europepmc +1 more source
Reoperation risk by subtype in proximal junctional kyphosis and the impact of osteoporosis treatment in adult spinal deformity surgery. [PDF]
Ohba T +5 more
europepmc +1 more source
Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products. [PDF]
Mattei AE +9 more
europepmc +1 more source

